Guardant Health Clia Number

Listing Websites about Guardant Health Clia Number

GUARDANT HEALTH INC. NPI 1184045619 - Health Providers Data

(8 days ago) WebCLIA Number: 05D2070300 Address: 505 PENOBSCOT DR REDWOOD CITY, CA ZIP 94063 Phone: (650) 290-7575 Get Directions GUARDANT HEALTH, INC. …

https://healthprovidersdata.com/hipaa/codes/NPI-1184045619-guardant-health-inc

Category: Health Show Health

05D2070300 CLIA NUMBER - GUARDANT HEALTH - Health …

(4 days ago) WebCLIA Number: 05D2070300 Facility Name: GUARDANT HEALTH Facility Address: 505 PENOBSCOT DR REDWOOD CITY, CA ZIP 94063 Get Directions Facility Phone …

https://healthprovidersdata.com/hipaa/codes/CLIA_05D2070300.aspx

Category: Health Show Health

Home - GuardantHealth

(7 days ago) WebOver 500,000 of our blood tests have been performed by 12,000 doctors to date. Our commercially available tests help inform treatment decisions for patients with advanced …

https://guardanthealth.com/

Category: Health Show Health

2023 Annual Notice to Physicians - GuardantHealth

(Just Now) WebThis letter serves as an annual notice on updates regarding the ordering and processing of clinical laboratory tests performed by Guardant Health, Inc. Guardant may update you …

https://guardanthealth.com/annualnotice/

Category: Health Show Health

Guardant Health - Labs - NIH Genetic Testing Registry (GTR) - NCBI

(5 days ago) WebGuardant Health, has 5 tests registered in GTR. Lab information includes contact information, lab directors and genetic counselors, description of tests and …

https://www.ncbi.nlm.nih.gov/gtr/labs/505502/

Category: Health Show Health

Guardant Health, Inc. - Resources - Investor Contacts

(7 days ago) WebBy providing your email address below, you are providing consent to Guardant Health Inc. to send you the requested Investor Email Alert updates. * Required. Email Address * …

https://investors.guardanthealth.com/resources/investor-contacts/default.aspx

Category: Health Show Health

Guardant Health, Inc. - Guardant Health Receives ADLT Status …

(8 days ago) WebGuardant Health, Inc. (Nasdaq: GH) announced that the Centers for Medicare Medicaid Services (CMS) has approved Advanced Diagnostic Laboratory Test …

https://investors.guardanthealth.com/press-releases/press-releases/2021/Guardant-Health-Receives-ADLT-Status-from-CMS-for-FDA-Approved-Guardant360-CDx-Test/default.aspx

Category: Health Show Health

Ship – Guardant Health

(1 days ago) WebDetailed instructions are available below the form. Back. * * * * * * * * Reset Fields Ship From / Pickup Address. Get Label. Schedule Pickup. Get Label. Find A Drop Off Location. Ship …

https://guardanthealth.eu/ship/

Category: Health Show Health

For Patients - GuardantHealth

(9 days ago) WebFor Shield™ patient support: Phone: 1.855.722.7335, ext. 1, then press 2. Email: [email protected]. And to learn more about our commitment to …

https://guardanthealth.com/precision-oncology/for-patients/

Category: Health Show Health

Guardant Health, Inc. - Investor Relations

(4 days ago) WebBy providing your email address below, you are providing consent to Guardant Health Inc. to send you the requested Investor Email Alert updates. * Required. Email Address * …

https://investors.guardanthealth.com/home/default.aspx

Category: Health Show Health

Guardant Health, Inc. - Guardant Health Introduces …

(9 days ago) WebNext-generation assay combines 800+-gene panel with exome-wide methylation detection to provide novel genomic and epigenomic insights into tumor, …

https://investors.guardanthealth.com/press-releases/press-releases/2022/Guardant-Health-Introduces-GuardantINFINITY-Smart-Liquid-Biopsy-for-Research-Use-to-Help-Bring-New-Cancer-Therapies-to-Patients-Sooner/default.aspx

Category: Health Show Health

Guardant Health (GH) Set to Announce Quarterly Earnings on

(7 days ago) WebGuardant Health had a negative net margin of 85.02% and a negative return on equity of 301.94%. On average, analysts expect Guardant Health to post $-3 EPS for …

https://www.marketbeat.com/instant-alerts/nasdaq-gh-earnings-date-2024-05-02/

Category: Health Show Health

142,745 Shares in Guardant Health, Inc. (NASDAQ:GH) Bought

(4 days ago) WebGuardant Health, Inc. has a 52 week low of $15.81 and a 52 week high of $41.06. The company has a market cap of $2.19 billion, a price-to-earnings ratio of -4.21 …

https://www.marketbeat.com/instant-alerts/nasdaq-gh-sec-filing-2024-04-30/

Category: Health Show Health

SHIELD Overview - GuardantHealth

(Just Now) WebAt Guardant Health, we believe a simple blood test can improve lung cancer screening compliance by overcoming barriers associated with current methods, such as low-dose …

https://guardanthealth.com/clinical-studies/shield-overview/

Category: Cancer Show Health

Guardant Health, Inc. - Guardant Health Launches Real-World …

(6 days ago) WebThe Guardant Health Oncology Platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs …

https://investors.guardanthealth.com/press-releases/press-releases/2020/Guardant-Health-Launches-Real-World-Clinical-Genomic-Platform-to-Accelerate-Precision-Oncology-Drug-Development/default.aspx

Category: Health Show Health

FDA Advisory Panel Review of Guardant Health’s Shield™ Blood …

(Just Now) WebPALO ALTO, Calif., April 22, 2024--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the Molecular and Clinical Genetics …

https://finance.yahoo.com/news/fda-advisory-panel-review-guardant-125200837.html

Category: Health Show Health

Guardant Health, Inc. - Guardant Health Receives FDA Emergency …

(8 days ago) WebCOVID-19 diagnostic expands testing supply, protects the continuity of essential cancer work at Guardant Health, and helps with reopening at Delaware State …

https://investors.guardanthealth.com/press-releases/press-releases/2020/Guardant-Health-Receives-FDA-Emergency-Use-Authorization-for-its-Guardant-19-Next-Generation-Sequencing-Based-COVID-19-Test/default.aspx

Category: Cancer Show Health

Guardant Health, Inc. - Guardant Health Presents New Data …

(6 days ago) Web- Multi-Cancer Assay Highly Sensitive and Specific in Screening for Detection of Early-Stage Cancers, Able to Identify Tumor Tissue of Origin with High Accuracy …

https://investors.guardanthealth.com/press-releases/press-releases/2022/Guardant-Health-Presents-New-Data-Showing-Blood-Test-Highly-Accurate-in-Detecting-Multiple-Cancers-at-the-American-Association-for-Cancer-Research-Annual-Meeting/default.aspx

Category: Cancer Show Health

Guardant Health, Inc. - Guardant Health Initiates ORACLE Study to

(6 days ago) Web1,000-patient prospective study in 11 solid tumors will monitor ctDNA levels up to five years Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology …

https://investors.guardanthealth.com/press-releases/press-releases/2021/Guardant-Health-Initiates-ORACLE-Study-to-Evaluate-Performance-of-Guardant-Reveal-Blood-Test-to-Predict-Recurrence-Across-Early-Stage-Cancers/default.aspx

Category: Health Show Health

Guardant Health, Inc. - Guardant Health Reports Fourth Quarter …

(6 days ago) WebFull year 2023 revenue growth of 25% driven by clinical volume growth of 39% Expects full year 2024 revenue to be in the range of $655 to $670 million Guardant …

https://investors.guardanthealth.com/press-releases/press-releases/2024/Guardant-Health-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-2024-Outlook/default.aspx

Category: Health Show Health

Guardant Health Reports First Quarter 2021 Financial Results

(5 days ago) WebAchieved revenue of $78.7 million, driven by approximately 18,400 clinical tests Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company …

https://investors.guardanthealth.com/press-releases/press-releases/2021/Guardant-Health-Reports-First-Quarter-2021-Financial-Results/default.aspx

Category: Health Show Health